Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1984 Nov;52(5):524–529. doi: 10.1136/hrt.52.5.524

Increased plasma cyclic nucleotide concentrations in congestive heart failure.

K Ogawa, H Shiozu, K Mizuno, M Ban, T Ito, T Satake
PMCID: PMC481675  PMID: 6093837

Abstract

Plasma concentrations of cyclic nucleotides (adenosine monophosphate (AMP) and guanosine monophosphate (GMP) were measured by an ultrasensitive radioimmunoassay in 138 patients with heart failure due to various causes. Measurements were related to the New York Heart Association classification of symptoms, plasma noradrenaline concentrations, and mean pulmonary artery pressures. Serial concentrations of cyclic AMP and GMP were also measured daily in four patients treated for acute left ventricular failure. Plasma concentrations of cycle AMP were related to the severity of the heart failure, plasma noradrenaline concentrations, and pulmonary artery pressures. Cyclic AMP concentrations fell rapidly after treatment of acute left ventricular failure. Plasma concentrations of cyclic GMP also depended on the severity of heart failure and the pulmonary artery pressure, and decreased sharply with treatment although remaining at a high value. The cyclic GMP concentrations were significantly higher in patients with mitral stenosis than in those with other types of heart failure.

Full text

PDF
528

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball J. H., Kaminsky N. I., Hardman J. G., Broadus A. E., Sutherland E. W., Liddle G. W. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest. 1972 Aug;51(8):2124–2129. doi: 10.1172/JCI107019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beck N. P., Kaneko T., Zor U., Field J. B., Davis B. B. Effects of vasopressin and prostaglandin E 1 on the adenyl cyclase-cyclic 3',5'-adenosine monophosphate system of the renal medulla of the rat. J Clin Invest. 1971 Dec;50(12):2461–2465. doi: 10.1172/JCI106746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beck N., Kim H. P., Kim K. S. Effect of metabolic acidosis on renal action of parathyroid hormone. Am J Physiol. 1975 May;228(5):1483–1488. doi: 10.1152/ajplegacy.1975.228.5.1483. [DOI] [PubMed] [Google Scholar]
  4. Broadus A. E., Kaminsky N. I., Hardman J. G., Sutherland E. W., Liddle G. W. Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. J Clin Invest. 1970 Dec;49(12):2222–2236. doi: 10.1172/JCI106441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brodows R. G., Ensinck J. W., Campbell R. G. Mechanism of plasma cyclic AMP response to hypoglycemia in man. Metabolism. 1976 Jun;25(6):659–663. doi: 10.1016/0026-0495(76)90063-9. [DOI] [PubMed] [Google Scholar]
  6. Cailla H. L., Racine-Weisbuch M. S., Delaage M. A. Adenosine 3',5' cyclic monophosphate assay at 10-15 mole level. Anal Biochem. 1973 Dec;56(2):394–407. doi: 10.1016/0003-2697(73)90205-4. [DOI] [PubMed] [Google Scholar]
  7. Cailla H. L., Vannier C. J., Delaage M. A. Guanosine 3', 5'-cyclicmonophosphate assay at 10(-15)-mole level. Anal Biochem. 1976 Jan;70(1):195–202. doi: 10.1016/s0378-5173(83)90100-x. [DOI] [PubMed] [Google Scholar]
  8. Dunham E. W., Haddox M. K., Goldberg N. D. Alteration of vein cyclic 3':5' nucleotide concentrations during changes in contractility. Proc Natl Acad Sci U S A. 1974 Mar;71(3):815–819. doi: 10.1073/pnas.71.3.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eckberg D. L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med. 1971 Oct 14;285(16):877–883. doi: 10.1056/NEJM197110142851602. [DOI] [PubMed] [Google Scholar]
  10. Goldberg N. D., O'Dea R. F., Haddox M. K. Cyclic GMP. Adv Cyclic Nucleotide Res. 1973;3:155–223. [PubMed] [Google Scholar]
  11. Goodman A. D., Steiner A. L., Pagliara A. S. Effects of acidosis and alkalosis on 3',5'-GMP and 3',5'-AMP in renal cortex. Am J Physiol. 1972 Sep;223(3):620–625. doi: 10.1152/ajplegacy.1972.223.3.620. [DOI] [PubMed] [Google Scholar]
  12. Hamet P., Lowder S. C., Hardman J. G., Liddle G. W. Effect of hypoglycemia on extracellular levels of cyclic AMP in man. Metabolism. 1975 Oct;24(10):1139–1144. doi: 10.1016/0026-0495(75)90150-x. [DOI] [PubMed] [Google Scholar]
  13. Hardman J. G., Davis J. W., Sutherland E. W. Effects of some hormonal and other factors on the excretion of guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate in rat urine. J Biol Chem. 1969 Dec 10;244(23):6354–6362. [PubMed] [Google Scholar]
  14. Henry D. P., Starman B. J., Johnson D. G., Williams R. H. A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. Life Sci. 1975 Feb 1;16(3):375–384. doi: 10.1016/0024-3205(75)90258-1. [DOI] [PubMed] [Google Scholar]
  15. Honma M., Satoh T., Takezawa J., Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med. 1977 Dec;18(3):257–273. doi: 10.1016/0006-2944(77)90060-6. [DOI] [PubMed] [Google Scholar]
  16. Honma M., Ui M. Plasma cyclic GMP: response to cholinergic agents. Eur J Pharmacol. 1978 Jan 1;47(1):1–10. doi: 10.1016/0014-2999(78)90367-9. [DOI] [PubMed] [Google Scholar]
  17. Kondo T., Ogawa K., Ban M., Ogasawara B., Watanabe E., Satake T. Plasma level of norepinephrine and cyclic nucleotides following acute myocardial infarction. Jpn Heart J. 1981 Jul;22(4):593–603. doi: 10.1536/ihj.22.593. [DOI] [PubMed] [Google Scholar]
  18. Kunitada S., Honma M., Ui M. Increases in plasma cyclic AMP dependent on endogenous catecholamines. Eur J Pharmacol. 1978 Mar 15;48(2):159–169. doi: 10.1016/0014-2999(78)90325-4. [DOI] [PubMed] [Google Scholar]
  19. Lake C. R., Ziegler M. G., Kopin I. J. Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci. 1976 Jun 1;18(11):1315–1325. doi: 10.1016/0024-3205(76)90210-1. [DOI] [PubMed] [Google Scholar]
  20. Ogawa K., Matsuno T., Tsuchiya S., Ban M., Minaguchi K. Plasma level of norepinephrine, cyclic AMP and cyclic GMP in essential hypertension. Jpn Circ J. 1981 Jun;45(6):654–660. doi: 10.1253/jcj.45.654. [DOI] [PubMed] [Google Scholar]
  21. Rabinowitz B., Kligerman M., Parmley W. W. Plasma cyclic adenosine 3'5'-monophosphate (AMP) levels in acute myocardial infarction. Am J Cardiol. 1974 Jul;34(1):7–11. doi: 10.1016/0002-9149(74)90085-x. [DOI] [PubMed] [Google Scholar]
  22. Rosman P. M., Agrawal R., Goodman A. D., Steiner A. L. Effect of angiotensin II on cyclic guanosine monophosphate and cyclic adenosine monophosphate in human plasma. J Clin Endocrinol Metab. 1976 Mar;42(3):531–536. doi: 10.1210/jcem-42-3-531. [DOI] [PubMed] [Google Scholar]
  23. Siddle K., Davies C. J., Shetty K. J., Elkeles R. S. The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma. Clin Sci Mol Med. 1976 Jun;50(6):487–491. doi: 10.1042/cs0500487. [DOI] [PubMed] [Google Scholar]
  24. Strange R. C., Mjos O. D. The sources of plasma cyclic AMP: studies in the rat using isoprenaline, nicotinic acid and glucagon. Eur J Clin Invest. 1975 Apr;5(2):147–152. doi: 10.1111/j.1365-2362.1975.tb00440.x. [DOI] [PubMed] [Google Scholar]
  25. Thomas J. A., Marks B. H. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978 Feb;41(2):233–243. doi: 10.1016/0002-9149(78)90162-5. [DOI] [PubMed] [Google Scholar]
  26. Tsuchiya S., Ogawa K., Satake T. Plasma levels of cyclic nucleotides in patients with essential hypertension. Jpn Heart J. 1980 Nov;21(6):803–815. doi: 10.1536/ihj.21.803. [DOI] [PubMed] [Google Scholar]
  27. Ui M., Honma M., Kunitada S., Okada F., Ide H., Hata S., Satoh T. Adrenergic and cholinergic modulation of extracellular cyclic nucleotides. Adv Cyclic Nucleotide Res. 1980;12:25–35. [PubMed] [Google Scholar]
  28. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES